Table 1. Baseline Characteristics of Patients with sAP, uAP, and AS.
| Stable AP (N = 16) | Unstable AP (N = 13) | AS (N = 16) | p value | |
|---|---|---|---|---|
| Age (yr), N = 45 | 71.4±10.0 | 71.6±3.6 | 71.8±13.1 | n.s |
| Gender (male/female), N = 45 | 10/6 | 10/3 | 9/7 | n.s |
| Height (cm), N = 45 | 158.9±8.6 | 162.5±8.0 | 159.4±8.2 | n.s |
| Weight (kg), N-45 | 61.3±12.6 | 65.5±12.9 | 61.2±11.5 | n.s |
| LVDd (mm), N = 42 | 48.9±8.4 | 52.0±6.1 | 47.7±6.5 | n.s |
| LVDs (mm), N = 42 | 35.2±10.2 | 38.2±8.5 | 33.1±6.2 | n.s |
| LVEF (%), N = 42 | 54.9±11.8 | 50.2±15.8 | 58.9±7.7 | n.s |
| Diabetes mellitus (%), N = 45 | 50.0 | 46.2 | 43.8 | n.s |
| Hypertension (%), N = 45 | 87.5 | 92.3 | 68.8 | n.s |
| Dyslipidemia (%), N = 45 | 81.3 | 69.2 | 62.5 | n.s |
| Active Smoker (%), N = 43 | 6.7 | 16.7 | 6.3 | n.s |
| Alcohol (%), N = 41 | 46.7 | 80.0 | 25.0 | 0.02 |
| ACEI or ARB (%), N = 45 | 62.5 | 69.2 | 56.3 | n.s |
| β-blocker (%), N = 45 | 25.0 | 30.8 | 31.3 | n.s |
| Oral hypoglycemic drug (%), N = 45 | 37.5 | 23.1 | 31.3 | n.s |
| Insulin (%), N = 45 | 18.8 | 15.4 | 12.5 | n.s |
| Statin or probucol (%), N = 45 | 56.3 | 53.9 | 43.8 | n.s |
| AST (IU/L), N = 42 | 21.6±7.2 | 32.6±14.8 | 18.9±6.4 | <0.01 |
| ALT (IU/L), N = 42 | 17.4±10.0 | 28.8±17.5 | 13.3±7.2 | <0.01 |
| LDL-cho (mg/dl), N = 42 | 110.6±33.9 | 113.4±35.0 | 104.0±38.1 | n.s |
| CK (mg/dl), N = 44 | 73.7±34.9 | 160.0±165.1 | 111.8±103.8 | n.s |
| Cr (mg/dl), N = 42 | 1.9±1.7 | 1.5±2.2 | 3.4±3.7 | n.s |
| eGFR (ml/min/1.73m2), N = 42 | 40.0±24.3 | 57.8±20.6 | 44.1±33.0 | n.s |
| Hb (g/dl), N = 44 | 12.4±2.0 | 12.7±2.1 | 11.6±1.7 | n.s |
| log2BNP (pg/ml), N = 42 | 6.4±2.0 | 7.3±2.2 | 7.8±2.7 | n.s |
| BS (mg/dl), N = 44 | 120.4±47.7 | 140.2±49.2 | 146.0±61.7 | n.s |
| HbA1c (%), N = 41 | 5.9±1.2 | 6.4±1.9 | 5.9±1.9 | n.s |
sAP, stable angina pectoris; uAP, unstable angina pectoris; AS, aortic stenosis; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDL-cho, low density lipoprotein; CK, creatine phosphokinase; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; BNP brain natriuretic peptide; BS, blood sugar; HbA1c, and hemoglobin A1c. All values are expressed as mean ± SD.